FDA Urged to Protect Patients from Payer-Mandated Drug Distribution Model

March 31, 2021

The AHA and American Society of Health-System Pharmacists urge the Food and Drug Administration to take appropriate enforcement action to protect patients from a payer-mandated drug distribution model known as “white bagging.”

Under the white bagging model, payers require patients to receive their medications through a narrow network of specialty pharmacies often affiliated with the payer, and providers to hold the medications until the patient arrives for treatment. 

View the entire letter under Key Resources.

Related Resources

Letter/Comment
Public
The Honorable Chiquita Brooks-LaSure Administrator Centers for Medicare & Medicaid Services Hubert H. Humphrey Building 200 Independence Avenue, S.W., Room…
Special Bulletin
Public
President Biden today signed an executive order (EO) establishing a “whole-of-government” effort to promote competition in the American economy. The EO…
Special Bulletin
Member
This Special Bulletin summarizes a proposed rule with additional policies for health insurance issuers and the Health Insurance Marketplaces (or “exchanges”)…
Special Bulletin
Public
After concerns raised by the AHA and other health groups, UnitedHealthcare today announced that it would delay until the end of the COVID-19 public health…
Letter/Comment
America’s hospitals and health systems are deeply concerned by UnitedHealthcare’s (UHC) recent policy announcement to allow for the retroactive denial of…
Fact Sheets
Some employers are moving away from offering traditional coverage with a provider network and instead are using reference-based pricing for some or all of…